Data Analysis

Slide background

Data Analysis

Rare disease drug development provides unique issues and challenges. Key among them is the smallness of the patient population, which complicates study design, study sizing and powering, study conduct, the handling of missing data, statistical analysis, and interpretability of study results.
Our rare disease biostatisticians and team can help before your study starts, during your study, and after your study ends. Contract with us per hour, per deliverable, per dedicated time. You’ll love our pricing.

1 in 10 Americans are affected by a rare disease.
Services Before Clinical Trial or Observational Study Starts
  • Study data analysis strategy and planning
  • DSMB analysis planning
  • Publication analysis planning
Services During Clinical Trial or Observational Study
  • Data review to ensure quality
  • Programming of tables, figures, listings, and profiles
  • Data graphics
  • DSMB analysis and reporting
Services After Database Locks/Data Cut, or Ends of Observational Study
  • Data mining
  • Data graphics
  • Interim analysis
  • Final analysis
  • Exploratory analysis
  • Integrated analysis
  • Publication analysis